ホーム › 膵臓がん › カリフォルニア州 › Orange
Orange、CAにおける膵臓がんの臨床試験
Orangeとその周辺地域（約30マイル以内）の拠点で、膵臓がんに関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
被験者募集中第1相
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- UC Irvine Health, Orange
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
被験者募集中第3相
- Investigative Site US049, Orange
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
被験者募集中第3相
- UC Irvine Health-Chao Family Comprehensive Cancer Center, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- UC IRVINE Health, Orange
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
被験者募集中第1相
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
被験者募集中第1/2相
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
被験者募集中
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
被験者募集中第3相
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Pancreatic Cancer Early Detection Consortium
被験者募集中観察研究健康なボランティア歓迎
- UC Irvine Health, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
被験者募集中第2相
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)
被験者募集中第1相
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Orange
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
被験者募集中第1/2相
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
他の都市における膵臓がんの試験
- Houston, TX61件の研究
- New York City, NY60件の研究
- Boston, MA43件の研究
- Nashville, TN39件の研究
- Los Angeles, CA35件の研究
- St. Louis, MO33件の研究
- Arlington, VA33件の研究
- San Antonio, TX31件の研究
- Baltimore, MD30件の研究
- Philadelphia, PA26件の研究
- Tampa, FL26件の研究
- Durham, NC24件の研究
Orangeにおける他の研究
- 非小細胞肺癌25件の研究
- 転移性癌20件の研究
- 卵巣がん16件の研究
- 大腸癌16件の研究
- 乳がん14件の研究
- 肝臓がん（肝細胞がん）14件の研究
- 前立腺がん14件の研究
- 悪性黒色腫14件の研究
- 肺がん14件の研究
- 胃癌13件の研究
- 大うつ病性障害13件の研究
- 急性骨髄性白血病13件の研究
ClinicalTrials.govより、2026/10/07時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。